This inventor holds 1 USPTO granted patent. Top assignee: Douglas Pharmaceuticals Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yuefeng Long and an Extended-Release Pharmaceutical Formulation.
Introduction
Yuefeng Long is an inventor based in Henderson, New Zealand. He is associated with Douglas Pharmaceuticals Limited and is named on 1 patent.
Latest Patents
Long’s patent, “Extended release pharmaceutical formulation,” describes a dosing regimen using an oral extended-release formulation for treatment-resistant depression and treatment-resistant anxiety.
Career Highlights
The available information identifies Long’s work in pharmaceutical innovation through his association with Douglas Pharmaceuticals Limited and his patent on an extended-release formulation.
Collaborations
Long’s listed company affiliation is Douglas Pharmaceuticals Limited. The provided information does not specify additional collaborators.
Conclusion
Yuefeng Long’s patent focuses on an oral extended-release formulation and dosing regimen intended to address treatment-resistant depression and anxiety.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile